Movatterモバイル変換


[0]ホーム

URL:


CN108774315A - PEGylated Norfloxacin and its antibacterial application - Google Patents

PEGylated Norfloxacin and its antibacterial application
Download PDF

Info

Publication number
CN108774315A
CN108774315ACN201810712926.1ACN201810712926ACN108774315ACN 108774315 ACN108774315 ACN 108774315ACN 201810712926 ACN201810712926 ACN 201810712926ACN 108774315 ACN108774315 ACN 108774315A
Authority
CN
China
Prior art keywords
norfloxacin
pegylated
polyethylene glycol
reaction
synthetic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810712926.1A
Other languages
Chinese (zh)
Inventor
李虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huateng Pharmaceutical Co Ltd
Original Assignee
Hunan Huateng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huateng Pharmaceutical Co LtdfiledCriticalHunan Huateng Pharmaceutical Co Ltd
Priority to CN201810712926.1ApriorityCriticalpatent/CN108774315A/en
Publication of CN108774315ApublicationCriticalpatent/CN108774315A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention relates to PEGylated Norfloxacin and its antibacterial application, the general structure of the derivative is as follows:Wherein, the molecular formula of polyethylene glycol (PEG) is:A is amino, carboxyl, methoxyl group, halogen, sulfydryl etc., and molecular weight is:1000-20000.The derivative has the shortcomings that water-soluble well, to overcome Norfloxacin poorly water-soluble, improves bacteriostatic activity, extends drug half-life, reduces dosage.

Description

PEGylated Norfloxacin and its antibacterial application
Technical field
The present invention relates to pesticide synthesis fields, and in particular to a kind of PEGylated Norfloxacin and its antibacterial application.
Background technology
Norfloxacin (Norfloxacin also known as Noroxin, Fulgram) is third generation Comprecin, is classWhite is to light yellow crystalline powder, odorless, mildly bitter flavor.Exposure is easy to moisture absorption in air, forms semihydrate.Meet it is photochromic graduallyIt deepens.In water or ethyl alcohol, solubility slightly soluble.But it is readily soluble in acid or alkaline solution.
Norfloxacin is to gram-negative bacterias such as Escherichia coli, shigella dysenteriae, Salmonella, proteus, Pseudomonas aeruginosasThere is height antibacterial activity, also has good antibacterial action to gram positive bacterias such as staphylococcus, Diplococcus pneumopniaes.But promise fluorine is huskyStar water solubility is poor, and half-life period is not grown, and side effect is larger.
Referred to as " PEG ", ethylene glycol is through high-molecular compound made of intermolecular dehydrating condensation for polyethylene glycol.According to average molecularQuality is different and property is different, from no color or smell thick liquid to waxy solid.It is liquid under 200~600 room temperature of molecular weightBody, molecular weight just gradually become semi-solid in 600 or more persons, and with the difference of average molecular weight, property is also variant.FromNo color or smell thick liquid is to waxy solid.This product is dissolved in water, ethyl alcohol and many other organic solvents.Due to polyethylene glycolSteam forces down, and stablizes to heat, acid, alkali.It does not work with many chemicals.There are good hygroscopicity, lubricity, caking property.NothingPoison, it is non-stimulated.Therefore there is critically important application prospect in fields such as medicine, material and engineerings.
Invention content
To solve the above-mentioned problems, The present invention gives a kind of technical solutions that PEG and Norfloxacin are connected.The Norfloxacin compound of PEG loads not only has good water solubility, but also substantially prolongs its half-life period, to carryIts high antibacterial and bactericidal activity.
The purpose of the present invention is to provide a kind of preparation method of PEGylated Norfloxacin and its application in antibacterial, PEGChange Norfloxacin, structural formula is:
Wherein, the molecular formula of polyethylene glycol (PEG) is:ForAmino, carboxyl, methoxyl group, halogen, sulfydryl etc., molecular weight are:1000-20000;
Further, A is methoxyl group or halogen;
Further, molecular weight polyethylene glycol 2000-10000.
The synthetic method of PEGylated Norfloxacin, it is characterized in that synthetic route as shown in Figure 1,
Step 1) polyethylene glycol is oxidized to the poly- second of end carboxyl two through TEMPO (2,2,6,6- tetramethyl piperidines-nitrogen-oxide)Alcohol;
Polyethylene glycol acyl chlorides is made in step 2) end carboxyl polyethylene glycol;
PEGylated Norfloxacin is made in step 3) polyethylene glycol acyl chlorides with Norfloxacin in the presence of alkali.
Further, which is characterized in that the step 1) be using dichloromethane as solvent under conditions of it is anti-in 0-30 DEG CTemperature is answered, is carried out under the reaction time of 6-12h.
The material ratio of the step 1) is polyethylene glycol:TEMPO:Sodium hypochlorite:Sodium chlorite=1:0.05:2:2.
Further, the reaction dissolvent of the step 1) has the buffer system of sodium bicarbonate.
Further, which is characterized in that the step 2) be using oxalyl chloride as solvent under conditions of in 60-80 DEG C of reactionTemperature carries out under the reaction time of 6-12h.
Further, which is characterized in that the step 3) be using dichloromethane as solvent under conditions of it is anti-in 0-30 DEG CTemperature is answered, is carried out under the reaction time of 4-10h.
Further, the required alkali of the step 3) is triethylamine.
The invention has the advantages that:
Norfloxacin after 1.PEG modifications, drug water solubility enhancing, increases pharmaceutical activity.
Norfloxacin Increased Plasma Half-life after 2.PEG modifications, reduces formulation rate.
Description of the drawings
Fig. 1 is the synthetic route of PEGylated Norfloxacin.
Specific implementation mode
Preparation method with reference to the conjugate of the embodiment description present invention and its antibacterial application, it does not limit this hairBright, the scope of the present invention is defined by the claims.
Embodiment 1:The preparation of compound 1
(1) addition 100g MPEG2000, the 500ml dichloromethane in 1L flasks, 20ml saturated sodium bicarbonate solutions,0.4gTEMPO.Under ice bath temperature control, 20ml liquor natrii hypochloritis is added dropwise, it is molten to continue dropwise addition 20ml sodium chlorites after stirring 1hLiquid, is warming up to 20 DEG C of stirring 6h, and reaction finishes.92g products are obtained after crystallization for purifying.Yield:92%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3):δ:3.579~3.540 (m, 182H);2.423 (t, J=6.8Hz, 2H).
(2) 10g steps (1) product is taken, is added in 50ml oxalyl chlorides, 65 DEG C of reaction 8h are warming up to.After completion of the reaction,It is cooled to room temperature, is directly spin-dried for, 10g products are obtained after anhydrous ether mashing, it can directly in next step, without being further purified.
(3) 10g steps (2) product is added in 100ml dichloromethane, 1.6g Norfloxacins, tri- second of 1.5g is addedAmine.20 DEG C of reaction 4h.After completion of the reaction, 50ml is washed 2 times, and anhydrous sodium sulfate drying is spin-dried for.Crystallization for purifying, anhydrous ether10.5g products are obtained after mashing.Yield:91.3%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3): δ:7.959 (m,1H);7.126 (d, J=4.4Hz, 1H);5.936 (d, J=4.4Hz, 1H);3.679~3.560 (m, 184H);3.423 (m,4H);3.124 (t, J=4.8Hz, 2H);2.373 (t, J=5.2Hz, 2H);1.141 (s, 3H).
Embodiment 2:The preparation of compound 2
(1) the addition 100g mpeg 3s 400 in 1L flasks, 500ml dichloromethane, 12ml saturated sodium bicarbonate solutions,0.24gTEMPO.Under ice bath temperature control, 12ml liquor natrii hypochloritis is added dropwise, it is molten to continue dropwise addition 12ml sodium chlorites after stirring 1hLiquid, is warming up to 20 DEG C of stirring 6h, and reaction finishes.93g products are obtained after crystallization for purifying.Yield:93%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3):δ:3.579~3.540 (m, 310H);2.423 (t, J=6.8Hz, 2H).
(2) 10g steps (1) product is taken, is added in 50ml oxalyl chlorides, 65 DEG C of reaction 8h are warming up to.After completion of the reaction,It is cooled to room temperature, is directly spin-dried for, 10g products are obtained after anhydrous ether mashing, it can directly in next step, without being further purified.
(3) 10g steps (2) product is added in 100ml dichloromethane, 0.95g Norfloxacins, tri- second of 0.88g is addedAmine.20 DEG C of reaction 4h.After completion of the reaction, 50ml is washed 2 times, and anhydrous sodium sulfate drying is spin-dried for.Crystallization for purifying, anhydrous ether10.4g products are obtained after mashing.Yield:94.3%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3):δ:7.959 (m,1H);7.126 (d, J=4.4Hz, 1H);5.936 (d, J=4.4Hz, 1H);3.679~3.560 (m, 312H);3.423 (m,4H);3.124 (t, J=4.8Hz, 2H);2.373 (t, J=5.2Hz, 2H);1.141 (s, 3H).
Embodiment 3:The preparation of compound 3
(1) addition 100g MPEG5000, the 500ml dichloromethane in 1L flasks, 8ml saturated sodium bicarbonate solutions,0.16gTEMPO.Under ice bath temperature control, 8ml liquor natrii hypochloritis is added dropwise, after stirring 1h continues that 8ml sodium chlorite solutions are added dropwise,20 DEG C of stirring 6h are warming up to, reaction finishes.94g products are obtained after crystallization for purifying.Yield:94%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3):δ:3.579~3.545 (m, 454H);2.425 (t, J=6.0Hz, 2H).
(2) 10g steps (1) product is taken, is added in 50ml oxalyl chlorides, 65 DEG C of reaction 10h are warming up to.After completion of the reaction,It is cooled to room temperature, is directly spin-dried for, 10g products are obtained after anhydrous ether mashing, it can directly in next step, without being further purified.
(3) 10g steps (2) product is added in 100ml dichloromethane, 0.64g Norfloxacins, tri- second of 0.6g is addedAmine.20 DEG C of reaction 6h.After completion of the reaction, 50ml is washed 2 times, and anhydrous sodium sulfate drying is spin-dried for.Crystallization for purifying, anhydrous ether10.0g products are obtained after mashing.Yield:94.0%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3): δ:7.959 (m,1H);7.126 (d, J=4.4Hz, 1H);5.936 (d, J=4.4Hz, 1H);3.679~3.560 (m, 456H);3.423 (m,4H);3.124 (t, J=4.8Hz, 2H);2.373 (t, J=5.2Hz, 2H);1.141 (s, 3H).
Embodiment 4:The preparation of compound 4
(1) addition 100g MPEG10000, the 500ml dichloromethane in 1L flasks, 4ml saturated sodium bicarbonate solutions,0.08gTEMPO.Under ice bath temperature control, 4ml liquor natrii hypochloritis is added dropwise, after stirring 1h continues that 4ml sodium chlorite solutions are added dropwise,20 DEG C of stirring 6h are warming up to, reaction finishes.91g products are obtained after crystallization for purifying.Yield:91%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3):δ:3.579~3.540 (m, 910H);2.423 (t, J=6.8Hz, 2H).
(2) 10g steps (1) product is taken, is added in 50ml oxalyl chlorides, 80 DEG C of reaction 12h are warming up to.After completion of the reaction,It is cooled to room temperature, is directly spin-dried for, 10g products are obtained after anhydrous ether mashing, it can directly in next step, without being further purified.
(3) 10g steps (2) product is added in 100ml dichloromethane, 0.32g Norfloxacins, tri- second of 0.3g is addedAmine.20 DEG C of reaction 4h.After completion of the reaction, 50ml is washed 2 times, and anhydrous sodium sulfate drying is spin-dried for.Crystallization for purifying, anhydrous ether10.0g products are obtained after mashing.Yield:96.9%.Nuclear magnetic data is as follows:1HNMR (400MHz, CDCl3): δ:7.959 (m,1H);7.126 (d, J=4.4Hz, 1H);5.936 (d, J=4.4Hz, 1H);3.679~3.560 (m, 912H);3.423 (m,4H);3.124 (t, J=4.8Hz, 2H);2.373 (t, J=5.2Hz, 2H);1.141 (s, 3H).
Embodiment 5:The antibacterial experiment in vitro of each target compound
1) test strain be chicken colibacillosis, swine escherichia coli, pig staphylococcus aureus, chicken staphylococcus aureus,Streptococcus;
2) bacteriostatic test is done with Beating holes method, measures inhibition zone size.Bacteriostatic diameter >=16mm is Gao Min, antibacterial straight11~15mm of diameter is quick in being, bacteriostatic diameter≤10mm is muting sensitive or drug resistance.
3) preparation of bacterium solution:Bacterial strain is accessed into broth bouillon, sets 37 DEG C of cultures for 24 hours.
4) preparation of antibacterial liquid:1mg drugs are dissolved in 20ml sterile waters, are shaken up, 5% concentration is made.
5) tablet culture:Cultured solution of broth and antibacterial liquid are pressed 1:1 mixing is placed on culture medium, then takes 0.1ml'sBacterium solution is added thereto, and sets 37 DEG C of cultures for 24 hours.Do two groups of parallel tests.
1 unit of table (mm)
As seen from table, PEGylated Norfloxacin compound and Norfloxacin all have gram-negative bacteria and gram positive bacteriaSensibility, 5 kinds of bacterial strains all show as hypersensibility to each compound.Chicken colibacillosis has highest sensibility, pig to compound 2Staphylococcus aureus has highest sensibility to compound 1.Each PEGylated Norfloxacin compound is relative to NorfloxacinBacteriostatic activity have advantage.

Claims (7)

CN201810712926.1A2018-06-272018-06-27PEGylated Norfloxacin and its antibacterial applicationPendingCN108774315A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201810712926.1ACN108774315A (en)2018-06-272018-06-27PEGylated Norfloxacin and its antibacterial application

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201810712926.1ACN108774315A (en)2018-06-272018-06-27PEGylated Norfloxacin and its antibacterial application

Publications (1)

Publication NumberPublication Date
CN108774315Atrue CN108774315A (en)2018-11-09

Family

ID=64031008

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201810712926.1APendingCN108774315A (en)2018-06-272018-06-27PEGylated Norfloxacin and its antibacterial application

Country Status (1)

CountryLink
CN (1)CN108774315A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102827365A (en)*2006-11-072012-12-19中国药科大学Amino acid connected with polyethylene glycol and preparation method and application for amino acid
CN104403011A (en)*2014-12-052015-03-11广西大学Preparation method of pH responsive material
CN105377319A (en)*2013-03-152016-03-02界面生物公司Compounds and compositions for drug release
US20160206742A1 (en)*2013-09-062016-07-21University Of Pittsburgh - Of The Commonwealth System Of Higher EducationMaterial to prevent post surgical infection
CN105849086A (en)*2012-11-242016-08-10杭州多禧生物科技有限公司Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102827365A (en)*2006-11-072012-12-19中国药科大学Amino acid connected with polyethylene glycol and preparation method and application for amino acid
CN105849086A (en)*2012-11-242016-08-10杭州多禧生物科技有限公司Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
CN105377319A (en)*2013-03-152016-03-02界面生物公司Compounds and compositions for drug release
US20160206742A1 (en)*2013-09-062016-07-21University Of Pittsburgh - Of The Commonwealth System Of Higher EducationMaterial to prevent post surgical infection
CN104403011A (en)*2014-12-052015-03-11广西大学Preparation method of pH responsive material

Similar Documents

PublicationPublication DateTitle
CN114634498B (en)Pleuromutilin derivative containing thiazole-pyridine benzyl quaternary ammonium salt side chain and preparation method and application thereof
CN105837530B (en)A kind of pleuromutilin derivative and its preparation method and application with piperazine sidechain
CN101367760A (en) The synthetic method of 2-chloronicotinic acid
CN106543054B (en) A pleuromutilin derivative with 2-aminoethanethiol side chain and its preparation method and application
ES2660988T3 (en) Production process of a pyrrole derivative and intermediate product thereof
Wang et al.Engineering a biomimicking strategy for discovering nonivamide-based quorum-sensing inhibitors for controlling bacterial infection
US10421715B2 (en)Pleuromutilin derivative having 2-amino phenyl mercaptan side chain as well as preparation method and application thereof
CN101337914A (en) A kind of preparation method of taurine and substituted taurine
CN105198785B (en)A kind of maleimide class compound and its preparation and application
CN108774315A (en)PEGylated Norfloxacin and its antibacterial application
Nuţă et al.Synthesis, characterization and antimicrobial activity evaluation of new agents from benzamides class
CN1331849C (en)Novel method for synthesizing thiamphenicol and florfenicol and its key intermediate product
CN103992337A (en)Convenient method for preparing aspoxicillin sodium
Liu et al.A facile solid phase synthesis of tetramic acid
JPH01287066A (en)Novel anthranilic acid derivative
CN106692138A (en)Application of N-benzylimidamide derivative as polymyxin antibiotic synergist
CN108929253B (en)Pleuromutilin compound and preparation method and application thereof
CN114751879A (en) A kind of furanyl double long chain quaternary ammonium salt compound, preparation method and application thereof
CN111718361B (en) A kind of metallo-beta-lactamase inhibitor and preparation method and application thereof
CN104926752B (en)Benzisothiazolinone acetamide derivative and synthesis method and application thereof
CN104292133B (en)The synthetic method of a kind of cancer therapy drug Vorinostat
Aparaschivei et al.Sulfonic derivatives of 2-Mercaptobenzoxazole and its conjugates with poly (maleic anhydride-alt-vinyl acetate) with potential pharmacological applications
CN102127021A (en)Preparation method of water-soluble amino acid-derived bisbenzimidazole salt
CN101274900A (en) 2-Hydroxyhalogenated benzyl amino acid compound and its preparation method and application
NO133427B (en)

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication

Application publication date:20181109

RJ01Rejection of invention patent application after publication

[8]ページ先頭

©2009-2025 Movatter.jp